Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...

For the fourth quarter and full-year 2024, Tempus AI announced its preliminary revenue numbers on Jan. 13. Per the announcement, fourth-quarter preliminary revenues were around $200 million ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024 ...

In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up sharply ...

CHICAGO, January 14, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite ...

Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...